Correlation Between Treasury Wine and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Treasury Wine and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Treasury Wine and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Treasury Wine Estates and Aquestive Therapeutics, you can compare the effects of market volatilities on Treasury Wine and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Treasury Wine with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Treasury Wine and Aquestive Therapeutics.
Diversification Opportunities for Treasury Wine and Aquestive Therapeutics
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Treasury and Aquestive is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Treasury Wine Estates and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Treasury Wine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Treasury Wine Estates are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Treasury Wine i.e., Treasury Wine and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Treasury Wine and Aquestive Therapeutics
Assuming the 90 days horizon Treasury Wine Estates is expected to under-perform the Aquestive Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Treasury Wine Estates is 1.4 times less risky than Aquestive Therapeutics. The pink sheet trades about -0.01 of its potential returns per unit of risk. The Aquestive Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 225.00 in Aquestive Therapeutics on August 30, 2024 and sell it today you would earn a total of 291.00 from holding Aquestive Therapeutics or generate 129.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 70.81% |
| Values | Daily Returns |
Treasury Wine Estates vs. Aquestive Therapeutics
Performance |
| Timeline |
| Treasury Wine Estates |
| Aquestive Therapeutics |
Treasury Wine and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Treasury Wine and Aquestive Therapeutics
The main advantage of trading using opposite Treasury Wine and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Treasury Wine position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| Treasury Wine vs. Aristocrat Group Corp | Treasury Wine vs. Naked Wines plc | Treasury Wine vs. Willamette Valley Vineyards | Treasury Wine vs. Andrew Peller Limited |
| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |